https://european-biotechnology.com/wp-content/uploads/2024/04/Geldbaum-pixabay.jpg340465Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-03-01 10:08:482024-07-12 12:56:20German HTGF IV fund closes at €493m
British anti-aging therapeutics developer 5 Alarm Bio Ltd has raised £500K in a seed financing for testing its lead compound FAB001 for healing chronic wounds.
French Abivax SA has raised €130m capital led by TCGX to accelerate Phase III testing of its ulcerative colitis candidate obefazimod extend its cashflow.
https://european-biotechnology.com/wp-content/uploads/2024/04/Abivax.jpg500839Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-22 21:48:132024-07-12 12:52:31Abivax SA raises €130m to advance obefazimod to Phase III
https://european-biotechnology.com/wp-content/uploads/2024/04/EB.com_Mark_Chadwick_Ingenza_kl.jpg12501245Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-02-22 11:14:322024-07-16 17:18:00Ingenza gets a new strategic business advisor
https://european-biotechnology.com/wp-content/uploads/2024/04/Devonyu.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-21 15:27:362024-07-12 12:51:14Paleo raised € 12 m in Series A financing round
https://european-biotechnology.com/wp-content/uploads/2024/04/RS5629_AdobeStock_127114772-scr.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-02-21 09:30:422024-07-12 12:49:16Minaris and LIfT BioSciences collaborate in cell therapy development
France-based Abivax SA announced the appointment of Sheldon Sloan, M.D., M. Bioethics, as its new Chief Medical Officer. He will assume the new role in the beginning of March.
PVH Corp has joined fiber-to-fiber consortium that wants to make textile recycling sustainable by establishing standards for biorecycled textile fibre.
German HTGF IV fund closes at €493m
Latest NewsThe fourth fund of High-Tech Gründerfonds has reached a final fund volume of €493.8m
Oxford Biomedica changes management
AppointmentsFormer Rentschler-CEO Dr Frank Mathias officially takes up his new position as CEO and board member of Oxford Biomedica at the end of March.
5 Alarm Bio Ltd raises £500K in seed round
Latest NewsBritish anti-aging therapeutics developer 5 Alarm Bio Ltd has raised £500K in a seed financing for testing its lead compound FAB001 for healing chronic wounds.
High blood pressure reprograms immune system
Latest NewsInterferon-gamma overexpression leads to hypertension-induced damage to the blood-brain barrier by reprogrammed macrophages.
Abivax SA raises €130m to advance obefazimod to Phase III
Latest NewsFrench Abivax SA has raised €130m capital led by TCGX to accelerate Phase III testing of its ulcerative colitis candidate obefazimod extend its cashflow.
Ingenza gets a new strategic business advisor
AppointmentsDr Mark Chadwick will bring extensive industry knowledge to his new role as Strategic Business Advisor at UK-based Ingenza Ltd.
Paleo raised € 12 m in Series A financing round
Latest NewsMyoglobin producer Paleo NV has closed a € 12 m Series A round led by DSM Venturing and Planet A Ventures.
Minaris and LIfT BioSciences collaborate in cell therapy development
Latest NewsCDMO Minaris Regenerative Medicine GmbH is to manufacture the leukocyte infusion therapy N-LIfT for LIFT BioSciences.
Abivax appoints new CMO
AppointmentsFrance-based Abivax SA announced the appointment of Sheldon Sloan, M.D., M. Bioethics, as its new Chief Medical Officer. He will assume the new role in the beginning of March.
PVH Corp joins fiber-to-fiber consortium
Latest NewsPVH Corp has joined fiber-to-fiber consortium that wants to make textile recycling sustainable by establishing standards for biorecycled textile fibre.